The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada

被引:10
作者
Sarma, Sisira [1 ]
Basu, Kisalaya [1 ]
Gupta, Anil [1 ]
机构
[1] Hlth Canada, Hlth Policy Branch, Appl Res & Anal Directorate, Microsimulat Modelling & Data Anal Div, Ottawa, ON K1A 0K9, Canada
关键词
insurance; Canada; drug utilization; psychotropic drug; non-psychotropic drug; latent class model;
D O I
10.1016/j.socscimed.2007.07.015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Using 2002 Canadian Community Health Survey data, this paper examines the effect of public and private prescription drug insurance on the utilization of psychotropic and non-psycho tropic drugs. It is found that prescription drug utilization is characterized by two stochastic regimes requiring use of latent class modelling framework. In many instances, results differ for the classes of high and low users of prescription drugs. After accounting for the unobserved individual heterogeneity and a number of socio-demographic factors, health status, and province fixed effects, we find that having prescription drug insurance (public or private) increases the expected number of non-psychotropic medications for both low and high users. Public insurance affects psychotropic drug utilization positively for the low-user group only. The statistical insignificance of insurance for the high-user psychotropic drugs or lower magnitude of insurance coefficients on high-user non-psychotropic drugs seems to stem from high inelastic demand for prescription drugs in the concerned groups. In addition, we find that age, self-reported health status, and long-term mental and physical health problem diagnosed by a health professional are important determinants of prescription drug utilization for both classes of users. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2553 / 2565
页数:13
相关论文
共 35 条
  • [1] The case for a Medicare drug coverage benefit: A critical review of the empirical evidence
    Adams, AS
    Soumerai, SB
    Ross-Degnan, D
    [J]. ANNUAL REVIEW OF PUBLIC HEALTH, 2001, 22 : 49 - 61
  • [2] [Anonymous], 1998, ECONOMETRIC SOC MONO
  • [3] [Anonymous], 2006, DOLL DALYS DEC EC AS
  • [4] Psychotropic Medication Use in Canada
    Beck, Cynthia A.
    Williams, Jeanne V. A.
    Wang, Jian Li
    Kassam, Aliya
    El-Guebaly, Nady
    Currie, Shawn R.
    Maxwell, Colleen J.
    Patten, Scott B.
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (10): : 605 - 613
  • [5] *CAN I HLTH ING, 2006, DRUG EXP CAN
  • [6] DEV P, 2002, J HLTH EC, V21, P601
  • [7] DEV P, 1997, J APPL ECONOMET, V12, P313
  • [8] Prescription drug benefits and Canada's uninsured
    Dewa, CS
    Hoch, JS
    Steele, L
    [J]. INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 2005, 28 (05) : 496 - 513
  • [9] Pharmacy benefits and the use of drugs by the chronically ill
    Goldman, DP
    Joyce, GF
    Escarce, JJ
    Pace, JE
    Solomon, MD
    Laouri, M
    Landsman, PB
    Teutsch, SM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (19): : 2344 - 2350
  • [10] On becoming 65 in Ontario - Effects of drug plan eligibility on use of prescription medicines
    Grootendorst, PV
    OBrien, BJ
    Anderson, GM
    [J]. MEDICAL CARE, 1997, 35 (04) : 386 - 398